Search hospitals > Ohio > Columbus

Ohio State University

Claim this profile
Columbus, Ohio 43210
Global Leader in Heart Failure
Global Leader in Adult T-Cell Leukemia/Lymphoma
Conducts research for Cancer
Conducts research for Lymphoma
Conducts research for High Blood Pressure
1255 reported clinical trials
214 medical researchers
Photo of Ohio State University in ColumbusPhoto of Ohio State University in Columbus

Summary

Ohio State University is a medical facility located in Columbus, Ohio. This center is recognized for care of Heart Failure, Adult T-Cell Leukemia/Lymphoma, Cancer, Lymphoma, High Blood Pressure and other specialties. Ohio State University is involved with conducting 1,255 clinical trials across 2,016 conditions. There are 214 research doctors associated with this hospital, such as Floor Backes, MD, Alice Mims, Uma Borate, MD, and Michael V Knopp, MD, PhD.

Area of expertise

1Heart Failure
Global Leader
Ohio State University has run 122 trials for Heart Failure. Some of their research focus areas include:
Stage III
BAROSTIM
Stage II
2Adult T-Cell Leukemia/Lymphoma
Global Leader
Ohio State University has run 104 trials for Adult T-Cell Leukemia/Lymphoma. Some of their research focus areas include:
CD19 positive
TP53 negative
MLLr positive

Top PIs

Clinical Trials running at Ohio State University

Melanoma
Lung Cancer
Cancer
Stroke
Myelofibrosis
Near-sightedness
Coronary Artery Disease
Post-Implantation Syndrome
Non-Small Cell Lung Cancer
Atrial Fibrillation
Image of trial facility.

Lifileucel + Pembrolizumab

for Melanoma

This is a Phase 3, multicenter, open-label, randomized, parallel group, treatment study to assess the efficacy and safety of lifileucel in combination with pembrolizumab compared with pembrolizumab alone in participants with untreated, unresectable or metastatic melanoma. Participants randomized to the pembrolizumab monotherapy arm who subsequently have a blinded independent central review- verified confirmed progressive disease (PD) will be offered lifileucel monotherapy in an optional crossover period.
Recruiting2 awards Phase 37 criteria
Image of trial facility.

IMA203

for Skin Cancer

This clinical trial is a prospective, multicenter, open-label, randomized, actively controlled, parallel-group Phase 3 clinical trial to evaluate the efficacy, safety and tolerability of treatment with IMA203 administered at the recommended phase 2 dose versus investigator's choice of treatment in patients with previously treated, unresectable or metastatic cutaneous melanoma.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Neoadjuvant Daromun + Surgery

for Melanoma

The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-free survival (RFS) of Stage IIIB/C melanoma patients with respect to the standard of care (surgery and adjuvant therapy).
Recruiting2 awards Phase 318 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Ohio State University?
Where is Ohio State University located?
Who should I call to ask about financial aid or insurance network?
What insurance does Ohio State University accept?
What awards or recognition has Ohio State University received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security